Quality Management in Drug Analysis

Abstract

References

1. Medicines Control Agency, Rules and Guidance for Pharmaceutical Manufacturers, Stationery Office, London, 1997.
2. A. Artiges, M. H. Loulergue and J. P. Reyneir, in International Pharmaceutical Product Registration, ed. Cartwright, A. C., and Matthews, B. R., Taylor and Francis, London, 1994, pp. 172–205.
3. C. R. Lee, J. P. Porziemsky, M. Gaspur and A. M. Krstulovic, LC–GC Int., 1996, 9, 414.
4. G. J. Sewell, J. Clin. Pharm. Ther., 1995, 20, 149.
5. J. C. Berridge, J. Pharm. Pharmacol., 1993, 45(Suppl. 1), 361.
6. J. Chamberlain, The Analysis of Drugs in Biological Fluids, CRC Press, Boca Raton, FL, 2nd edn., 1995.
7. R. C. Baselt and R. H. Cravey, Disposition of Toxic Drugs and Chemicals in Man, Chemical Toxicology Institute, Foster City, CA, USA, 4th edn., 1995.
8. R. C. Baselt, Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology, PSG, Littleton, MA, USA, 2nd edn., 1987.
9. A. C. Mehta, Anal. Proc., 1995, 32, 347.
10. D. R. A. Uges, P. Bouma, H. Pietersma and J. Meijer-Koens, Eur. Hosp. Pharm., 1996, 2, 4.
11. C. K. Lai, T. Lee, K. M. Au and A. Y. W. Chan, Clin. Chem., 1997, 43, 312.
12. J. Caldwell, J. Chromatogr., 1996, 719, 3.
13. Chiral Separations by HPLC: Applications to Pharmaceutical Compounds, ed. Krstulovic, A. M., Ellis Horwood, Chichester, 1989.
14. P. Camilleri, V. Biasi and A. Hutt, Chem. Br., 1994, 30, 43.
15. C. Burgess and R. D. McDowall, LC–GC Int., 1997, 10, 87.
16. L. Huber and M. Thomas, LC–GC Int., 1995, 8, 572.
17. L. Huber, LC–GC Int., 1996, 9, 564.
18. R. D. McDowall, LC–GC Int., 1996, 9, 202.
19. W. Horwitz, Anal. Chem., 1978, 50, 521A.
20. Royal Pharmaceutical Society, British National Formulary, Pharmaceutical Press, Wallingford, 1997.
21. Association of British Pharmaceutical Industry, Data Sheet Compendium, Datapharm Publications, London, 1996.
22. Martindale, The Extra Pharmacopoeia, Pharmaceutical Press, Wallingford, 31st edn., 1996.
23. The Merck Index, an Encyclopedia of Chemicals, Merck, Rahway, NJ, 12th edn., 1996.
24. The Pharmaceutical Codex, ed. Lund, W., Pharmaceutical Press, London, 1994.
25. Handbook of Pharmaceutical Excipients, ed. Wade, A., and Weller, P. J., Pharmaceutical Press, London, 2nd edn., 1994.
26. K. A. Connors, G. L. Amidon and V. J. Stella, Chemical Stability of Pharmaceuticals, Wiley, Chichester, 2nd edn., 1986.
27. L. A. Trissel, Handbook on Injectable Drugs, American Society of Hospital Pharmacists, Bethesda, MD, 9th edn., 1996.
28. J. C. Berridge, J. Pharm. Biomed. Anal., 1995, 14, 7.
29. International Conference on Harmonisation (ICH): Note for Guidance on Impurities in New Drug Substances, Commission of the European Communities, Brussels, 1995.
30. Clarke's Isolation and Identification of Drugs, ed. Moffat, A. C., Pharmaceutical Press, London, 2nd edn., 1986.
31. Analytical Profiles of Drug Substances, ed. Florey, K., Academic Press, New York, 1972–91, vols. 1–20 (each volume contains a cumulative index).
32. Analytical Profiles of Drug Substances and Excipients, ed. Brittain, H. G., Academic Press, New York, 1992–94, vols. 21–23 (each volume contains a cumulative index).
33. L. R. Snyder, J. L. Glajch and J. J. Kirkland, Practical HPLC Method Development, Wiley, Chichester, 2nd edn., 1997.
34. J. P. Boehlert, Drug Dev. Ind. Pharm., 1984, 10, 1343.
35. H. M. McNair, LC–GC Int., 1993, 6, 740.
36. M. J. Bowker, Analyst, 1996, 121, 91R.
37. J. W. Dolan, LC–GC Int., 1997, 10, 80.
38. T. Hamoir and D. L. Massart, in Advances in Chromatography, ed. Brown, P. R., and Grushka, E., Marcel Dekker, New York, 1993, vol. 33, pp. 97–145.
39. T. Hamoir, B. Bourguignon and D. L. Massart, Chromatographia, 1994, 39, 339.
40. G. S. Clarke, J. Pharm. Biomed. Anal., 1994, 12, 643.
41. G. P. Carr and J. C. Wahlich, J. Pharm. Biomed. Anal., 1990, 8, 613.
42. P. A. D. Edwardson, G. Bhaskar and J. E. Fairbrother, J. Pharm. Biomed. Anal., 1990, 8, 929.
43. J. M. Green, Anal. Chem., 1996, 68, 305A.
44. T. D. Wilson, J. Pharm., Biomed. Anal., 1990, 8, 389.
45. D. R. Jenke, J. Liq. Chromatogr. Relat. Technol., 1996, 19, 719.
46. D. R. Jenke, J. Liq. Chromatogr. Relat. Technol., 1996, 19, 737.
47. D. R. Jenke, J. Liq. Chromatogr. Relat. Technol., 1996, 19, 1873.
48. A. C. Mehta, J. Clin. Pharm. Ther., 1989, 14, 465.
49. I. Molnar, LC–GC Int., 1996, 9, 800.
50. I. Molnar, LC–GC Int., 1997, 10, 32.
51. Analytical Method Validation: Bioavailability, Bioequivalence, and Pharmacokinetic Studies, Conference Report, J. Pharm. Sci., 1992, 81, 309.
52. A. R. Buick, M. V. Doig, S. C. Jeal, G. S. Land and R. D. McDowall, J. Pharm. Biomed. Anal., 1990, 8, 629.
53. L. J. Phillips, J. Alexander and H. M. Hill, in Analysis for Drugs and Metabolites Including Anti-infective Agents, ed. Reid, E., and Wilson, I. D., Royal Society of Chemistry, Cambridge, 1990, pp. 23–36.
54. R. J. N. Tanner, in Analysis for Drugs and Metabolites Including Anti-infective Agents, ed. Reid, E., and Wilson, I. D., Royal Society of Chemistry, Cambridge, 1990, pp. 57—63.
55. A. C. Mehta, Talanta, 1987, 34, 609.
56. J. R. Lang and S. Bolton, J. Pharm. Biomed. Anal., 1991, 9, 357.
57. J. R. Lang and S. Bolton, J. Pharm. Biomed. Anal., 1991, 9, 435.
58. D. Dadger and P. E. Burnett, J. Pharm. Biomed. Anal., 1995, 14, 23.
59. International Conference on Harmonisation (ICH): Validation of Analytical Procedures, Note for Guidance, Commission of the European Communities, Brussels, 1995.
60. G. P. R. Carr, J. C. Wahlich and R. J. N. Tanner, in International Pharmaceutical Product Registration, ed. Cartwright, A. C., and Matthews, B. R., Taylor and Francis, London, 1994, pp. 246–306.
61. G. P. Carr and J. Wahlich, J. Pharm. Biomed. Anal., 1990, 8, 619.
62. R. D. McDowall, LC–GC Int., 1995, 8, 196.
63. British Pharmacopoeia 1993, HM Stationery office, London, 1993.
64. United States Pharmacopeia 1995, Mack, Easton, PA, 22nd revision, 1995.
65. J. C. Miller and J. N. Miller, Analyst, 1988, 113, 1351.
66. J. N. Miller, Analyst, 1991, 116, 3.
67. J. C. Miller and J. N. Miller, Statistics for Analytical Chemistry, Ellis Horwood, Chichester, 2nd edn., 1988.
68. M. T. Gilbert, I. Barinov-Colligon and J. R. Miksic, J. Pharm. Biomed. Anal., 1995, 13, 385.
69. P. A. Toseland, in Clarke's Isolation and Identification of Drugs, ed. Moffat, A. C., Pharmaceutical Press, London, 2nd edn., 1986, pp. 111–117.
70. Royal Pharmaceutical Society, Guidelines for a Pharmacy Based Pharmacokinetic Service, Pharm. J., 1985, 234, 626.
71. A. C. Mehta, J. Clin. Pharm. Ther., 1989, 14, 285.
72. R. D. McDowall, LC–GC Int., 1995, 8, 384.
73. N. T. Crosby, Anal. Proc., 1991, 28, 138.
74. A. G. Causy, H. M. Hill and L. J. Phillips, J. Pharm. Biomed. Anal., 1990, 8, 625.
75. J. A. Gardner, S. Coleman and S. G. Farrow, Anal. Proc., 1993, 30, 292.
76. E. Mullins, Analyst, 1994, 119, 369.
77. D. Burnett and J. Williams, in Clarke's Isolation and Identification of Drugs, ed. Moffat, A. C., Pharmaceutical Press, London, 2nd edn., 1986, pp. 118–127.
78. J. F. Wilson, L. M. Tsanaclis, J. E. Perrett, J. Williams, J. F. C. Wicks and A. Richens, Ther. Drug Monit., 1992, 14, 98.
79. L. M. Tsanaclis and J. F. Wilson, Clin. Chem., 1993, 39, 851.
80. L. Huber and K. Mandelatz, Int. Lab., 1994, 24, 19.
81. L. Huber and J. A. Rogers, Int. Lab., 1995, 25, 10.
82. L. Huber, Int. Lab., 1995, 25, 9.
83. Quality in the Analytical Laboratory, ed. Newman, E. J., Wiley, Chichester, 1995.
84. Guidelines for Achieving Quality in Trace Analysis, ed. Sargent, M., and MacKay, G., Royal Society of Chemistry, Cambridge, 1995.